Provided by Tiger Trade Technology Pte. Ltd.

TherapeuticsMD

2.28
+0.210010.14%
Post-market: 2.300.0200+0.88%19:30 EDT
Volume:212.20K
Turnover:476.14K
Market Cap:26.39M
PE:-121.61
High:2.30
Open:2.20
Low:2.17
Close:2.07
52wk High:2.95
52wk Low:0.9900
Shares:11.57M
Float Shares:9.49M
Volume Ratio:11.38
T/O Rate:2.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0187
EPS(LYR):-0.0527
ROE:-1.08%
ROA:-2.88%
PB:0.97
PE(LYR):-43.23

Loading ...

TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
May 12

TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
May 09

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 06

TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
May 05

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 02

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
May 01

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 29

TherapeuticsMD Inc. Stock Sheds 5.5%, Underperforms Market

Dow Jones
·
Apr 28

TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Apr 23

TherapeuticsMD Inc. Stock Rises 5.8%, Outperforms Market

Dow Jones
·
Apr 21

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 15

TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 08

TherapeuticsMD Inc. Stock Rallies 10.0%, Outperforms Market

Dow Jones
·
Apr 07

TherapeuticsMD Explains Brief Delay In Annual Filing

TIPRANKS
·
Apr 01

TherapeuticsMD delays 2025 10-K after filing omits auditor report

Reuters
·
Apr 01

TherapeuticsMD Inc. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
Apr 01

TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy

TIPRANKS
·
Mar 31

TherapeuticsMD Q4 EPS $(0.06) Down From $0.01 YoY, Sales $893.000K Up From $667.000K YoY

Benzinga Earnings
·
Mar 31

TherapeuticsMD Inc. Stock Slides 5.2%, Underperforms Market

Dow Jones
·
Mar 31

TherapeuticsMD reports FY25 EPS (6c) vs. (20c) last year

TIPRANKS
·
Mar 31